Author:
Watanabe Reiko,Tokuhira Michihide,Kizaki Masahiro
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Japanese Society of Myeloma. Treatment guidelines of multiple myeloma. Version 3: Bunkodo 2012.
2. NCCN guidelines. Version 1. 2013 multiple myeloma.
3. Palumbo A, Anderson K. Multiple myeloma. New Engl J Med. 2011;364:1046–60.
4. Moreau P, Richardson PG, Cavo M, Orlowski RZ, San Miguel JF, Palumbo A, Harousseau JL. Proteasome inhibitor in multiple myeloma: 10 years later. Blood. 2012;120:947–59.
5. Harousseau JL, Attal M, Avet-Loiseau H, Marit G, Caillot D, Mohty M, Lenain P, Hulin C, Facon T, Casassus P, Michallet M, Maisonneuve H, Benboubker L, Maloisel F, Petillon MO, Webb I, Mathiot C, Moreau P. Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005–01 phase III trial. J Clin Oncol. 2010;28:4621–9.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献